Clinical guide SEOM on venous thromboembolism in cancer patients

被引：0
作者：
A. J. Muñoz Martín
C. Font Puig
L. M. Navarro Martín
P. Borrega García
M. Martín Jiménez
机构：
[1] Gregorio Marañón University General Hospital,Medical Oncology Service
[2] Hospital Clinic i Provincial,Servicio de Oncología Médica
[3] University Hospital of Salamanca,Hospital de Día
[4] Cáceres Hospital Complex,Medical Oncology Service
来源：
Clinical and Translational Oncology | 2014年 / 16卷
关键词：
Cancer; Thrombosis; Guidelines; Anticoagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Venous thromboembolism (VTE) is a common event in cancer patients and one of the major causes of cancer-associated mortality and a leading cause of morbidity. In recent years, the incidence rates of VTE have notably increased; however, VTE is still commonly underestimated by oncologists. VTE is considered an adverse prognostic factor in cancer patients in all settings. In 2011 the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of prophylaxis and treatment of VTE in cancer patients. In an effort to incorporate evidence obtained since the original publication, SEOM presents an update of the guideline for thrombosis and cancer in order to improve the prevention and management of VTE.
引用
收藏
页码：1079 / 1090
页数：11
相关论文
共 252 条
[1]  
Epstein AS(2012)Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer Cancer 118 3053-3061
[2]  
Soff GA(2000)Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 1846-1850
[3]  
Capanu M(2008)GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 924-926
[4]  
Crosbie C(2008)Rating quality of evidence of and strength of recommandations BMJ 336 1049-1051
[5]  
Shah MA(2006)Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial BMJ 332 325-329
[6]  
Kelsen DP(1999)A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 793-800
[7]  
Sørensen HT(2004)Randomized, placebo-controlled trial of dalteparin for the prevention of venous thrombo-embolism in acutely ill medical patients Circulation 110 874-879
[8]  
Mellemkjaer L(2014)Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer Am J Med 127 82-86
[9]  
Olsen JH(2006)A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project Ann Surg 243 89-95
[10]  
Baron JA(2009)Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery Cochrane Database Syst Rev 1 CD004318-e70
12345678910